<!DOCTYPE html>
<html lang="en">
  <head>
    <meta charset="utf-8" />
    <title>Ad Atomica - AI-Powered Drug Discovery</title>
    <meta name="viewport" content="width=device-width, initial-scale=1" />
    <meta
      name="description"
      content="A closed loop, AI powered drug discovery system. Drug discovery – 100x faster, 100x cheaper."
    />
    <!-- Open Graph / Twitter -->
    <meta property="og:title" content="Ad Atomica - AI-Powered Drug Discovery" />
    <meta
      property="og:description"
      content="A closed loop, AI powered drug discovery system. Drug discovery – 100x faster, 100x cheaper."
    />
    <meta property="og:type" content="website" />
    <meta property="og:url" content="https://www.adatomica.com/" />
    <meta
      property="og:image"
      content="https://www.adatomica.com/assets/link-preview-open-graph-image.png"
    />
    <meta name="twitter:card" content="summary_large_image" />
    <meta
      name="twitter:image"
      content="https://www.adatomica.com/assets/link-preview-twitter-image.png"
    />
    <link rel="icon" type="image/png" href="assets/logo.png" />
    <link rel="stylesheet" href="styles.css" />
  </head>
  <body>
    <nav class="navbar">
      <div class="nav-container">
        <div class="nav-brand">
          <img src="assets/logo.png" alt="Ad Atomica Logo" class="nav-logo" />
          <span class="nav-title">Ad Atomica</span>
        </div>
        <div class="nav-links">
          <a href="#process">Our Process</a>
          <a href="#team">Meet the Team</a>
          <a href="#contact" class="nav-cta">Get in Touch</a>
        </div>
      </div>
    </nav>

    <main id="main-content">
      <!-- Hero Section -->
      <section class="hero">
        <div class="hero-content">
          <h1 class="hero-title">Ad Atomica</h1>
          <p class="hero-subtitle">A closed loop, AI powered drug discovery system.</p>
          <div class="hero-actions">
            <a href="#contact" class="btn btn-primary">Get in Touch</a>
            <a href="#team" class="btn btn-secondary">Meet the Team</a>
            <a href="#process" class="btn btn-secondary">Our Process</a>
          </div>
        </div>
      </section>

      <!-- Process Section -->
      <section id="process" class="section">
        <div class="container">
          <h2 class="section-title">A closed loop drug discovery process</h2>
          <p class="section-intro">
            Ad Atomica's proprietary platform represents a paradigm shift in pharmaceutical development.
            By harnessing advanced artificial intelligence and iterative optimisation, we've created a
            seamless, circular workflow that transforms target identification into validated lead candidates
            at unprecedented speed and cost efficiency.
          </p>
          <p class="section-intro">
            Our closed loop system integrates computational design with experimental validation, enabling
            rapid iteration and continuous learning. Each cycle refines our models, enhancing predictive
            accuracy and accelerating the path from concept to candidate. This approach eliminates the
            bottlenecks that plague traditional drug discovery, where linear workflows and disconnected
            stages create costly delays.
          </p>

          <div class="process-steps">
            <div class="process-step">
              <h3>Select Target</h3>
            </div>
            <div class="process-step">
              <h3>Design & Test</h3>
            </div>
            <div class="process-step">
              <h3>Analyse Results</h3>
            </div>
            <div class="process-step">
              <h3>Refine & Iterate</h3>
            </div>
          </div>

          <h3 class="subsection-title">Key Advantages of Our Platform</h3>

          <div class="advantages">
            <div class="advantage-card">
              <h4>Multi-Parameter Optimisation</h4>
              <p>
                Our AI simultaneously optimises for drug likeness, ADMET properties, target affinity,
                and selectivity eliminating traditional trade-offs between potency and pharmaceutical viability.
              </p>
            </div>
            <div class="advantage-card">
              <h4>Atom-by-Atom Construction</h4>
              <p>
                Unlike template based approaches, we build molecules from first principles, exploring
                vast chemical space to discover novel scaffolds that conventional methods would miss entirely.
              </p>
            </div>
            <div class="advantage-card">
              <h4>Continuous Learning Loop</h4>
              <p>
                Every synthesis and assay result feeds back into our models, creating a virtuous cycle
                where each iteration improves our predictive power and design sophistication.
              </p>
            </div>
          </div>

          <p class="section-outro">
            The result is a fundamentally more efficient discovery engine. Where traditional medicinal
            chemistry programmes might screen thousands of compounds over years, Ad Atomica's platform
            designs highly optimised candidates in weeks, dramatically reducing both time-to-clinic and
            development costs whilst maintaining rigorous scientific standards.
          </p>
        </div>
      </section>

      <!-- Team Section -->
      <section id="team" class="section section-alt">
        <div class="container">
          <h2 class="section-title">The Team</h2>
          <p class="section-intro">
            Ad Atomica's founding team combines entrepreneurial execution, deep technical expertise,
            and scientific rigour. Together, we're building the future of computational drug discovery
            with a pragmatic, results-driven approach.
          </p>

          <div class="team-grid">
            <div class="team-member">
              <img src="assets/adam.png" alt="Adam Davis" class="team-photo" />
              <h3>Adam Davis</h3>
              <h4>Chief Executive Officer</h4>
              <p>
                Adam leads Ad Atomica's commercial strategy, partnerships, and overall execution. He
                brings a founder's track record of delivering complex, capital-intensive projects at pace,
                having previously built a company that developed over £30 million of real estate across
                the United Kingdom.
              </p>
              <p>
                In early 2025, a personal experience using large language models to interpret clinical
                signals during his father's hospitalisation sparked Adam's fascination with AI-driven
                medicine. This pivotal moment led him to explore the transformative potential of
                artificial intelligence in healthcare and subsequently assemble Ad Atomica's exceptional team.
              </p>
            </div>

            <div class="team-member">
              <img src="assets/lygon.png" alt="Lygon Bowen-West" class="team-photo" />
              <h3>Lygon Bowen-West</h3>
              <h4>Chief Technology Officer</h4>
              <p>
                Lygon is a full-stack engineer with seven years' experience building robust, scalable
                systems. His background includes two years automating bioinformatics pipelines for
                research scientists, giving him unique insight into the computational challenges facing
                modern drug discovery.
              </p>
              <p>
                At Ad Atomica, Lygon architects and develops our entire technology platform, ensuring
                our AI systems are production-ready, scientifically rigorous, and capable of handling
                the computational demands of real-world pharmaceutical development.
              </p>
            </div>

            <div class="team-member">
              <img src="assets/alex.png" alt="Alex Dean" class="team-photo" />
              <h3>Alex Dean</h3>
              <h4>Chief Research Officer</h4>
              <p>
                Alex brings a formidable research pedigree to Ad Atomica, holding a PhD in artificial
                intelligence and a master's degree in theoretical physics. This combination of deep
                learning expertise and fundamental scientific training positions him uniquely to tackle
                the complex challenges of computational molecular design.
              </p>
              <p>
                With two years' experience at an AI consulting startup, Alex seamlessly bridges the
                gap between cutting-edge research and practical implementation, building the machine
                learning systems that power Ad Atomica's discovery platform.
              </p>
            </div>
          </div>

          <h3 class="subsection-title">Scientific Advisory Board</h3>
          <p class="section-intro">
            Our scientific advisers provide world-class expertise in oncology therapeutics and synthetic
            chemistry, ensuring Ad Atomica's platform meets the rigorous standards of pharmaceutical development.
          </p>

          <div class="advisors">
            <div class="advisor-card">
              <img src="assets/charles.jpeg" alt="Professor Charles Coombes" class="advisor-photo" />
              <h4>Oncology Expert</h4>
              <h3>Professor Charles Coombes</h3>
              <p>
                A renowned oncologist with decades of experience in cancer therapeutics development and
                approximately 50,000 scientific citations, Professor Coombes brings unparalleled clinical
                and translational expertise to Ad Atomica.
              </p>
              <p>
                He was part of the pioneering team that developed Samuraciclib, a CDK7 inhibitor,
                demonstrating his deep understanding of targeted cancer therapy development. Professor
                Coombes currently serves as Chair of The Imperial Cancer Research (UK) Centre Steering
                Committee, positioning him at the forefront of oncology innovation.
              </p>
            </div>

            <div class="advisor-card">
              <img src="assets/till.jpeg" alt="Professor Till Opatz" class="advisor-photo" />
              <h4>Chemistry Expert</h4>
              <h3>Professor Till Opatz</h3>
              <p>
                Internationally recognised for groundbreaking research in natural products synthesis and
                organic chemistry with approximately 10,000 scientific citations, Professor Opatz ensures
                our designed molecules are synthetically accessible and scalable.
              </p>
              <p>
                His specialisation in the design and scalable synthesis of bioactive molecules is crucial
                for translating Ad Atomica's computational designs into real-world drug candidates.
                Professor Opatz's expertise bridges the gap between in silico prediction and practical
                chemistry, a critical capability for any AI-driven discovery platform.
              </p>
            </div>
          </div>

          <h3 class="subsection-title">Strategic Partnerships</h3>
          <p class="section-intro">
            Ad Atomica is actively exploring collaborative partnerships with leading academic institutions
            and pharmaceutical companies. We believe the future of drug discovery lies in combining
            computational innovation with established expertise in target biology, medicinal chemistry,
            and clinical development.
          </p>

          <div class="partnerships">
            <div class="partnership-card">
              <h4>Academic Collaborations</h4>
              <p>
                Partner with us to access cutting-edge AI capabilities whilst advancing fundamental
                research in computational chemistry and drug design.
              </p>
            </div>
            <div class="partnership-card">
              <h4>Industry Partnerships</h4>
              <p>
                Accelerate your discovery programmes with our platform, reducing timelines and costs
                whilst exploring novel chemical space for your therapeutic targets.
              </p>
            </div>
            <div class="partnership-card">
              <h4>Target Specific Programmes</h4>
              <p>
                Co develop programmes in oncology, immunology, or other therapeutic areas where rapid,
                cost effective lead generation creates strategic advantage.
              </p>
            </div>
          </div>
        </div>
      </section>

      <!-- Contact Section -->
      <section id="contact" class="section">
        <div class="container">
          <h2 class="section-title">Get in Touch</h2>
          <p class="section-intro">
            We welcome conversations with investors, pharmaceutical partners, and academic collaborators
            who share our vision of transforming drug discovery through artificial intelligence. Whether
            you're interested in partnership opportunities, investment discussions, or simply learning
            more about our platform, we'd be delighted to connect.
          </p>

          <div class="contact-card">
            <h3>Adam Davis</h3>
            <h4>Chief Executive Officer</h4>
            <p>
              <strong>Email:</strong> <a href="mailto:adam@adatomica.com">adam@adatomica.com</a><br>
              <strong>Phone:</strong> <a href="tel:+447809613723">+44 7809 613723</a>
            </p>
            <a href="mailto:adam@adatomica.com" class="btn btn-primary">Send Email</a>
          </div>
        </div>
      </section>
    </main>

    <footer class="footer">
      <div class="container">
        © <span id="current-year"></span> Ad Atomica. All rights reserved.
      </div>
    </footer>

    <script>
      document.getElementById("current-year").textContent = new Date().getFullYear();
    </script>
  </body>
</html>
